Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.

Costea T, Vlad OC, Miclea LC, Ganea C, Szöllősi J, Mocanu MM.

Int J Mol Sci. 2020 Jan 8;21(2). pii: E401. doi: 10.3390/ijms21020401. Review.


Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer.

Costea T, Nagy P, Ganea C, Szöllősi J, Mocanu MM.

Int J Mol Sci. 2019 Mar 1;20(5). pii: E1062. doi: 10.3390/ijms20051062. Review.


Chemoprevention of Colorectal Cancer by Dietary Compounds.

Costea T, Hudiță A, Ciolac OA, Gălățeanu B, Ginghină O, Costache M, Ganea C, Mocanu MM.

Int J Mol Sci. 2018 Nov 28;19(12). pii: E3787. doi: 10.3390/ijms19123787. Review.


Epigallocatechin-3-O-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines.

Filippi A, Picot T, Aanei CM, Nagy P, Szöllősi J, Campos L, Ganea C, Mocanu MM.

Int J Food Sci Nutr. 2018 Aug;69(5):584-597. doi: 10.1080/09637486.2017.1401980. Epub 2017 Nov 21.


Detection of protein interactions by Subcellular Localization Assay.

Mocanu MM, Nagy P, Szöllősi J.

Cytometry A. 2017 Jul;91(7):657-658. doi: 10.1002/cyto.a.23153. Epub 2017 Jul 12. No abstract available.


ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.

Filippi A, Ciolac OA, Ganea C, Mocanu MM.

J Oncol. 2017;2017:1532534. doi: 10.1155/2017/1532534. Epub 2017 Feb 13. Review.


Fullerenol C60(OH)16 prevents amyloid fibrillization of Aβ40-in vitro and in silico approach.

Bednarikova Z, Huy PD, Mocanu MM, Fedunova D, Li MS, Gazova Z.

Phys Chem Chem Phys. 2016 Jul 28;18(28):18855-67. doi: 10.1039/c6cp00901h. Epub 2016 Jun 28.


Chemoprevention of Breast Cancer by Dietary Polyphenols.

Mocanu MM, Nagy P, Szöllősi J.

Molecules. 2015 Dec 17;20(12):22578-620. doi: 10.3390/molecules201219864. Review.


Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells.

Baran I, Ionescu D, Filippi A, Mocanu MM, Iftime A, Babes R, Tofolean IT, Irimia R, Goicea A, Popescu V, Dimancea A, Neagu A, Ganea C.

Leuk Res. 2014 Jul;38(7):836-49. doi: 10.1016/j.leukres.2014.04.010. Epub 2014 May 4.


Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.

Mocanu MM, Ganea C, Georgescu L, Váradi T, Shrestha D, Baran I, Katona E, Nagy P, Szöllősi J.

J Nat Prod. 2014 Feb 28;77(2):250-7. doi: 10.1021/np4007712. Epub 2014 Jan 23.


Polymorphism of hen egg white lysozyme amyloid fibrils influences the cytotoxicity in LLC-PK1 epithelial kidney cells.

Mocanu MM, Ganea C, Siposova K, Filippi A, Demjen E, Marek J, Bednarikova Z, Antosova A, Baran I, Gazova Z.

Int J Biol Macromol. 2014 Apr;65:176-87. doi: 10.1016/j.ijbiomac.2014.01.030. Epub 2014 Jan 18.


Mitochondrial respiratory complex I probed by delayed luminescence spectroscopy.

Baran I, Ionescu D, Privitera S, Scordino A, Mocanu MM, Musumeci F, Grasso R, Gulino M, Iftime A, Tofolean IT, Garaiman A, Goicea A, Irimia R, Dimancea A, Ganea C.

J Biomed Opt. 2013 Dec;18(12):127006. doi: 10.1117/1.JBO.18.12.127006.


Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoids.

Baran I, Ganea C, Privitera S, Scordino A, Barresi V, Musumeci F, Mocanu MM, Condorelli DF, Ursu I, Grasso R, Gulino M, Garaiman A, Musso N, Cirrone GA, Cuttone G.

Oxid Med Cell Longev. 2012;2012:498914. doi: 10.1155/2012/498914. Epub 2012 Jul 3.


Comparative analysis of fluorescence resonance energy transfer (FRET) and proximity ligation assay (PLA).

Mocanu MM, Váradi T, Szöllosi J, Nagy P.

Proteomics. 2011 May;11(10):2063-70. doi: 10.1002/pmic.201100028. Epub 2011 Apr 8.


Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells.

Baran I, Ganea C, Scordino A, Musumeci F, Barresi V, Tudisco S, Privitera S, Grasso R, Condorelli DF, Ursu I, Baran V, Katona E, Mocanu MM, Gulino M, Ungureanu R, Surcel M, Ursaciuc C.

Cell Biochem Biophys. 2010 Dec;58(3):169-79. doi: 10.1007/s12013-010-9104-1.


The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.

Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, Drexler D, Petrova O, Schönig K, Bujard H, Mandelkow E, Zhou L, Rune G, Mandelkow EM.

J Neurosci. 2008 Jan 16;28(3):737-48. doi: 10.1523/JNEUROSCI.2824-07.2008.


The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy.

Eckermann K, Mocanu MM, Khlistunova I, Biernat J, Nissen A, Hofmann A, Schönig K, Bujard H, Haemisch A, Mandelkow E, Zhou L, Rune G, Mandelkow EM.

J Biol Chem. 2007 Oct 26;282(43):31755-65. Epub 2007 Aug 23.


Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides.

Goldsbury C, Mocanu MM, Thies E, Kaether C, Haass C, Keller P, Biernat J, Mandelkow E, Mandelkow EM.

Traffic. 2006 Jul;7(7):873-88. Epub 2006 May 25.


Associations of ErbB2, beta1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell lines.

Mocanu MM, Fazekas Z, Petrás M, Nagy P, Sebestyén Z, Isola J, Tímár J, Park JW, Vereb G, Szöllosi J.

Cancer Lett. 2005 Sep 28;227(2):201-12.


Supplemental Content

Loading ...
Support Center